BioCentury

1:03 AM GMT, Jun 3, 2009
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical News

GSK's Armala meets Phase III RCC endpoint

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) reported that Armala

Read the full 73 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.